Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Deaths from cardiovascular disease are elevated on polluted days and for two days afterwards, according to research presented at ESC Preventive Cardiology 2023

News | Heart Failure

Air Pollution Linked with Elevated Risk of Fatal Heart Attacks and Strokes

April 14, 2023 — Deaths from cardiovascular disease are elevated on polluted days and for two days afterwards, according ...

April 14, 2023

Researchers have found that digital breast tomosynthesis (DBT) has improved breast cancer screening performance in community practice and identifies more invasive cancers, compared to digital mammography. In addition, radiologists’ interpretive performance improved with DBT

News | Pediatric Cardiology

Wireless Pacemakers May be Safe, Effective for Children with Irregular Heart Rhythms

April 13, 2023 — Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term ...

April 13, 2023

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population

News | Radiopharmaceuticals and Tracers

Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds

April 13, 2023 — A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin ...

April 13, 2023

Findings from a clinical trial on treating hypertension, published in the Journal of the American Medical Association (JAMA), highlight the potential of personalized medicine in cardiovascular care, and in the future, could improve treatment adherence, patient outcomes, and the cost-effectiveness of blood pressure-lowering medication.

News | Hypertension

Study on Blood Pressure Treatment Sheds Light on Value of Personalized Medicine in Cardiovascular Care

April 12, 2023 — Results from the Precision Hypertension Care Study (PHYSIC) showed that personalized blood pressure ...

April 12, 2023

The new partnership expands Acarix sales organization with 16 additional sales teams covering initially 30 new states across the United States

News | Artificial Intelligence

Acarix Accelerates US Commercialization into 30 Additional States

April 11, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced a strategic sales partnership ...

April 11, 2023

Five new hospitals have implemented the Daxor Corporation’s BVA-100 blood volume diagnostic for clinical use to guide fluid management in heart failure patients during the first quarter of 2023

News | Heart Failure

Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

April 11, 2023 — Daxor Corporation, a global leader in blood volume measurement technology, announced five new ...

April 11, 2023

A newly-published study in the Journal of the American College of Cardiology (JACC) focused on the impact of moderate exercise in patients using statins.

News | ACC

Moderate-intensity exercise found not to exacerbate muscle injury by statin users

April 11, 2023 — A newly-published study in the Journal of the American College of Cardiology, JACC, the flagship ...

April 11, 2023

The survey reflects the opinions of healthcare cybersecurity professionals that are responsible for either day-to-day operations or oversight of healthcare cybersecurity programs

News | Cybersecurity | By Melinda Taschetta-Millane

2022 HIMSS Healthcare Cybersecurity Survey Report Results Published

April 10, 2023 — The 2022 HIMSS Healthcare Cybersecurity Survey results were recently published. The survey reflects the ...

April 10, 2023

News | Cardiovascular Education

NCD Academy Launches New Health Equity and Social Determinants of Health Course

April 10, 2023 — Viatris Inc., a global healthcare company, and the American College of Cardiology (ACC) today released ...

April 10, 2023

GUARDIAN Registry data presented at ACC 2023 has shown use of the Paragonix SherpaPak Cardiac Transport System was associated with improved outcomes as compared to the use of traditional cold storage in LVAD patients undergoing Heart Transplantation

News | Heart Failure

Latest Clinical Evidence Points to Paragonix SherpaPak as a Tool to Reduce Unpredictable, Severe Complications following Heart Transplantation

April 6, 2023 — Paragonix Technologies, Inc., a leading organ transplant company, announces new research from a multi ...

April 06, 2023

Working with researchers from America’s top institutions, Dr. Peter Kowey is senior author of a study assessing treatment for a condition linked to high stroke risk

News | Atrial Fibrillation

Ablation is Safe and Effective in Treating Atrial Fibrillation, Research Guided by Main Line Health Expert Shows

April 6, 2023 — Atrial fibrillation (AFib) not only causes shortness of breath and palpitations but puts patients at ...

April 06, 2023

Part-time degree format will provide vital skills for career advancement in cardiac device interventional technologies

News | Cardiovascular Education

Harding University Introduces New Professional Pathway Tailored to Cardiac Professionals for its Master of Science in Cardiac Function and Interventional Technology

April 4, 2023 — Harding University has announced it will offer a new degree format for its Master of Science in cardiac ...

April 04, 2023

North America to account for larger share in atrial fibrillation market during 2022–2028; growth driven by rising geriatric population, increasing occurrence of cardiovascular diseases, high accessibility to advanced technologies, growing development of innovative and technologically advanced products, and increasing healthcare expenditure

Feature | Atrial Fibrillation

Atrial Fibrillation Market Reaches $20.92B, According to New Report

According to our latest study on "Atrial Fibrillation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by ...

April 04, 2023

The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood pressure in youth were outlined in a new scientific statement from the American Heart Association, published March 30 in the Association’s Hypertension journal.

News | Hypertension

Children with High Blood Pressure in Spotlight with AHA Journal Scientific Statement

April 4, 2023 — The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood ...

April 04, 2023

Results demonstrate significant reductions in LDL-C, hsCRP and cardiovascular risk in patients who are unable to maximize or tolerate a statin

News | Pharmaceuticals

Landmark CLEAR Outcomes Study Demonstrates NEXLETOL (bempedoic acid) Tablet is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad Population

April 3, 2023 — Esperion announced the full results from the landmark Cholesterol Lowering via Bempedoic acid, an ACL ...

April 03, 2023